PharmaLectures.com

Courses › Pharma industry foundations › Europe is not one market: generics country by country, from Germany to the Balkans

Europe is not one market: generics country by country, from Germany to the Balkans

Your generic bids stop failing on local rules your team never saw.

  • 15 audio modulesthree lengths each
  • 2 h 30 min to 12 h 30 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • BD, managementwho it is written for

Why this training matters

Your team bids in a German sickness fund discount tender and misses one requirement in the tender terms. The fund excludes the bid. Six months of preparation are gone, and a rival who read the fine print takes the share.

What changes after this course

Your business development team files market access applications across Europe that fit local rules the first time. You hold a certificate for each learner and a training record showing who finished which module. Bids reach review without avoidable delays.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your business development team stops guessing at local requirements when drafting entry plans. The French dossier goes to the Agence Nationale de Sécurité du Médicament and the Italian one to the Agenzia Italiana del Farmaco with the right documents in it. Fewer requests for more information come back, and the launch date holds.

Pricing is settled before the negotiation, not during it. Your managers put the Romanian clawback tax and Greek reference pricing into the first revenue model. Hospital access plans follow the Spanish decentralised procurement model and what each regional health authority asks for, so no region is a surprise.

Regulatory staff match each submission to the national rule that applies. They prepare the dossier for the route you chose, and they plan for German Festbetrag groups and sickness fund discount tenders from the start. A competitor who reads tender terms faster stops being a threat to your share.

Strategic planners forecast by country instead of by continent. They work with the Swedish pharmaceutical benefits system, count what parallel imports take in the Nordics, and subtract Polish patient co-payments and pharmacy fees well before launch. The forecast you show the board holds up when someone asks where a number came from.

Who needs this training

  • Business Development Manager, Europe

    The German or Italian tender terms land on your desk with a short deadline. You spot the requirement that would get your generic bid excluded before it is sent.

  • Head of Market Access, Generics

    You open the pricing talk with a figure that already includes the Romanian clawback tax and French generic group rules, so the revenue projection survives the first review.

  • Commercial Director, Central and Eastern Europe

    You line up the Polish reimbursement law criteria and the Serbian marketing authorisation forms against your entry plan, and you see which country should go first.

  • Strategic Planning Lead, Global Generics

    You replace the single European sales model with country models, and you can show why Spanish regional procurement limits how fast your product reaches patients.

Roles: Owner, CEO and board, Business development and export sales

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Write a German market entry plan that accounts for sickness fund discount tenders and Festbetrag groups.
  2. Prepare a price proposal for the Comité Economique des Produits de Santé that you can defend line by line.
  3. Identify the regional formulary listings an Italian hospital needs before it will stock your generic.
  4. Structure a Spanish access plan that treats each regional health authority as its own buyer.
  5. Check a product against the Polish reimbursement law criteria before applying for listing.
  6. Adjust generic pricing for the Swedish pharmaceutical benefits system and its product-of-the-period rule.

What the company gets

  • Your firm stops losing generic tenders to avoidable local compliance errors.
  • Bids sent to national health authorities arrive with the documents each one asks for, so initial reviews do not stall on missing items.
  • Revenue projections include regional taxes, co-payments and reference pricing rules, so the board sees a realistic figure before launch.
  • Each learner finishes with a certificate and a training record entry, so you can show who has been trained on which market.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 15 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h 30 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard6 h 15 min25 min a module, for regulatory, quality and business-development staff
Expanded12 h 30 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h 30 min
Business development and export salesBriefing2 h 30 min

Course outline: 15 modules

15 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Name the growth drivers behind generics across the European Union

    • How to explain to your board why one generic earns very different returns in each country.
    • Why patent expiry dates and approval routes decide your launch month more than demand does.
    • When the centralised, decentralised or mutual recognition route fits your product, and when not.
  2. 2Plan your German generic entry around sickness fund contracts

    • How to read a sickness fund discount contract before you price, not after you lose the bid.
    • Why Festbetrag groups cap what the fund pays and where that leaves your launch price.
    • What to settle with your team before the first German tender deadline appears.
  3. 3Clear the German regulatory checks before your generic launches

    • The dossier documents that stop a German submission from coming back with questions.
    • Why one missing item in the tender terms ends a bid before anyone looks at your price.
    • What to do when your wholesaler cannot get stock to German pharmacies in time.
  4. 4Set a French generic price that holds up in negotiation

    • How to walk into the Comité Economique des Produits de Santé with a price you can defend.
    • The steps that put your product on the French reimbursable list, in the order they happen.
    • Why French generic groups and the tarif forfaitaire de responsabilité set your room on price.
  5. 5Predict how French rivals and pharmacists move your generic share

    • How pharmacist substitution turns a listed generic into real volume, or into none.
    • The substitution rules at the French counter that your sales forecast must respect.
    • What the Agence Nationale de Sécurité du Médicament asks for before it authorises your product.
  6. 6Draft an Italian generic entry plan that the regions accept

    • How to bid for Italian regional hospital tenders without a surprise from the region.
    • What the Agenzia Italiana del Farmaco must approve on price, and when to ask.
    • Why co-payment rules change whether Italian patients end up with your generic.
  7. 7Set Italian generic prices and distribution before talks start

    • How to fix your ex-factory price before public price talks begin, not during them.
    • The regional formulary listings that open Italian hospital doors for your product.
    • Where Italian supply chains trap generic distributors, and how to spot it early.
  8. 8Build a Spanish market access plan that works region by region

    • How Spanish decentralised procurement changes who you pitch to and in what order.
    • What regional health authorities ask for when they pick a drug, before you apply.
    • Why the reference price system sets how competitive your generic can be.
  9. 9Size the generic opportunity in Poland before you commit

    • How to check your product against the Polish reimbursement law before you apply for listing.
    • How the Ministry of Health runs price negotiations, and what to bring to the table.
    • Why patient co-payments and pharmacy fees move your Polish forecast.
  10. 10Adapt your generic strategy to each Nordic market

    • How purchasing in Denmark, Finland and Norway differs, so one bid plan does not stretch over all three.
    • How the Swedish product-of-the-period rule picks the one generic that pharmacies dispense for a month.
    • What parallel imports do to your Nordic share, and when to price against them.
  11. 11Enter the Baltic generic markets one country at a time

    • How Estonia, Latvia and Lithuania each run reimbursement, so you stop treating them as one market.
    • The access barrier in each Baltic country that your entry plan has to name.
    • Why international generic firms stall in Baltic markets, and how to avoid the same stall.
  12. 12Judge the generic potential of Croatia and Serbia

    • How Croatian health insurance buys medicines, and where your bid fits in that process.
    • Which marketing authorisation forms Serbia requires, so your file is complete at first filing.
    • Why public tenders matter for hospital sales in both countries, and how to prepare for them.
  13. 13Set generic strategy for Slovenia and Bulgaria

    • How Slovenian pricing mechanisms set your generic margin before you ship a single pack.
    • Which regulatory pathway clears market access in Bulgaria, and what it asks of you.
    • What parallel trade does to generic availability and local price in both markets.
  14. 14Protect generic margins in Romania and Greece

    • How the Romanian clawback tax cuts into your margin, and where to put it in your model.
    • How Greek reference pricing limits your reimbursement and what that does to your price.
    • Which supply chain fixes keep stock moving in these two markets.
  15. 15Forecast where European generics go next and plan for it

    • How coming European Union pharmaceutical legislation could change your market access plans.
    • Which emerging therapy areas leave room for new generics in your next planning cycle.
    • How to turn all of this into a roadmap your board can fund in stages.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

15 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h 30 min in the briefing length and 12 h 30 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for BD, management. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 135 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team